Columbus NCORP RFA-CA-18-016

自1983年成立以来，哥伦布CCOP，现在被称为哥伦布NCORP，一直 一直致力于在俄亥俄州中部和东南部提供高质量的癌症护理选择 以及通过癌症研究试验推进癌症研究。哥伦布NCORP已经 在此期间发展到包括20个附属公司和子附属公司，有100名医生担任 调查人员。NCORP为从城市到农村的各种人群提供服务 阿巴拉契亚。在下一个授权期的六年内，NCORP计划继续 以提高这种能力，提高其参与、协助设计和 成功实施广泛的癌症研究试验，包括治疗、癌症 控制、筛查/监测、副作用预防/管理和癌症护理服务 研究性研究。NCORP在所有领域都取得了成功，并计划在#年继续发展。 它有能力调查其所在地区的健康差距并增加癌症的参与率 服务不足的社区进行的研究，包括少数群体、农村社区和 那些在阿巴拉契亚地区的。癌症护理服务的研究一直是并将继续是一个关键 作为这一目标的组成部分，正在继续改善整个联合体的护理做法。 NCORP附属机构、非肿瘤学专家、初级医生之间的密切合作 护理医生和社区组织是实现这一目标的关键。哥伦布NCORP计划 继续通过靶向和基因组技术追求癌症研究的前沿 治疗，同时寻找和实施直接适用的试验 对于我们地区发病率最高的癌症：乳腺癌、结肠癌和肺癌。 在过去担任NCORP的五年中，以及在担任哥伦布CCOP之前的30年中， 这些领域一直是一个高度优先的领域，并将继续作为我们积极追求的目标 将推进癌症护理科学并最好地服务于我们当地社区的治疗方法。 俄亥俄州中部和东南部在这些地区面临的独特挑战使哥伦布 NCORP为癌症研究做出真正和持久的贡献，以及在这里学到的教训 广泛适用于全国各地区。

Since its founding in 1983, the Columbus CCOP, now known as the Columbus NCORP, has been dedicated to providing high quality cancer care options in Central and Southeast Ohio as well as advancing cancer research through cancer research trials. The Columbus NCORP has grown in that time to encompass 20 affiliates and sub-affiliates, with 100 doctors serving as investigators. The NCORP serves a wide variety of populations, from urban areas to rural Appalachia. Over the six years comprising the next grant period, the NCORP plans to continue to grow in that capacity, improving its ability to participate in, assist with the design of, and successfully implement a wide range of cancer research trials, including treatment, cancer control, screening/surveillance, side effect prevention/management, and cancer care delivery research studies. In all areas the NCORP has been successful and plans to continue to grow in its ability to investigate health disparities in its region and increase participation in cancer research by underserved communities including minority populations, rural communities and those in Appalachian areas. Cancer care delivery research has been and continues to be a key component of this goal, as is continuing to improve care practices throughout the consortium. Close collaboration between NCORP affiliate institutions, non-oncology specialists, primary care physicians and community organizations is key to this goal. The Columbus NCORP plans to continue to pursue the cutting edge of cancer research through targeted and genomic therapies, while simultaneously seeking out and implementing trials that are directly applicable to those cancers with the highest incidence rate in our region: breast, colon and lung cancers. Over the past five years as an NCORP, and over the preceding 30 years as the Columbus CCOP, these areas have been a high priority and will continue to be as we aggressively pursue treatments that will advance the science of cancer care and best serve our local communities. The unique challenges facing Central and Southeast Ohio in these areas position the Columbus NCORP to make real and lasting contributions to cancer research, and the lessons learned here are widely applicable to regions across the country.